Data gathered: December 9
Data Bits
Data Bits | Value / Change | Benchmark | |
---|---|---|---|
Job Posts | 5 25% |
|
|
Sentiment | 94 0% |
|
|
Webpage traffic | 17,000 29.8% |
|
|
Employee Rating | 70 0% |
|
|
Google Adspend | $5,044 -89.4% | N/A | |
Google Trends | -100% |
|
|
Linkedin Employees | 220 N/A |
|
|
Patents | 15 0% |
|
|
4chan Mentions | 0% |
|
|
Facebook Engagement | 4 0% |
|
|
Facebook followers | 1,461 0% |
|
|
Stocktwits Mentions | 5 0% |
|
|
Stocktwits Subscribers | 596 0.2% |
|
|
Twitter Followers | 747 N/A |
|
|
Youtube Subscribers | 218 0% |
|
|
Instagram Followers | 276 0% |
|
|
News Mentions | 0% |
|
|
Reddit Mentions | 0% |
|
|
Business outlook | 83 0% |
|
In the news
CVRx (CVRX) is on the Move, Here's Why the Trend Could be SustainableDecember 7 - Yahoo |
|
CVRx (CVRX) Moves 7.1% Higher: Will This Strength Last?December 3 - Yahoo |
|
CVRx (CVRX) Price Target Increased by 5.15% to 20.81November 26 - Fintel |
|
Craig-Hallum Releases a Buy Rating on CVRx (CVRX)November 26 - TipRanks |
|
CVRx price target raised to $24 from $22 at Craig-HallumNovember 26 - Thefly.com |
|
CVRX Crosses Above Average Analyst TargetNovember 26 - ETF Channel |
About CVRx
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases.

Price | $24.74 |
Target Price | Sign up |
Market Cap | $495M |
Dividend Yield | 0 |
Industry | Medical Devices |
Similar companies
Company | Price | AI Score | |
---|---|---|---|
![]() |
Boston ScientificBSX |
$54.95 0% | 61 |
![]() |
Edwards LifesciencesEW |
$69.31 0.2% | 44 |
![]() |
Intuitive SurgicalISRG |
$310.69 0% | 67 |
![]() |
MedtronicMDT |
$79.64 0% | 60 |
![]() |
StrykerSYK |
$289.43 0% | 73 |
Financial performance View All
Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | |
---|---|---|---|---|---|
Q3 '23 | 11M | 1.7M | 8.8M | -9M | -8.5M |
Q2 '23 | 9.5M | 1.5M | 8M | -12M | -11M |
Q1 '23 | 8M | 1.3M | 6.7M | -11M | -11M |
Q4 '22 | 7.2M | 1.5M | 5.7M | -11M | -10M |
Q3 '22 | 6.2M | 1.3M | 4.8M | -9.8M | -9.8M |
Insider Transactions
VERRASTRO PAUL filed to sell 2,628 shares at $17.5. August 2 '23 |
VERRASTRO PAUL filed to sell 4,400 shares at $12.5. November 30 '22 |